GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Float Percentage Of Total Shares Outstanding

IXSBF (InNexus Biotechnology) Float Percentage Of Total Shares Outstanding : 0.00% (As of Sep. 23, 2024)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InNexus Biotechnology's float shares is 0.00 Mil. InNexus Biotechnology's total shares outstanding is 163.20 Mil. InNexus Biotechnology's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InNexus Biotechnology's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InNexus Biotechnology's Institutional Ownership is 0.18%.

InNexus Biotechnology Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

InNexus Biotechnology's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/163.20
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InNexus Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ONTX TSXV:APC APOP BTHE BOM:532871 GLPH AURX PTEO TSXV:PBS TIKRF NVIV BRTX TSXV:COT AKAOQ ATMS CAPS HSTC BOM:542765 MNTMD TSXV:MFS
Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
Website
http://www.ixsbio.com
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology Headlines

No Headlines